Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
PaperCitations, authors & open-access status
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,003 citations, 2023 year and hybrid oa status.
1,003
Citations
2023
Year
hybrid
OA Status